We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

226 hedge funds and large institutions have $1.12B invested in Ironwood Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 93 increasing their positions, 79 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

39,455% more call options, than puts

Call options by funds: $73.6M | Put options by funds: $186K

18% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 79

2.32% less ownership

Funds ownership: 110.12% → 107.8% (-2.3%)

13% less funds holding

Funds holding: 261 → 226 (-35)

26% less capital invested

Capital invested by funds: $1.5B → $1.12B (-$383M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

60% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 52

Holders
226
Holders Change
-35
Holders Change %
-13.41%
% of All Funds
3.26%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
21
Increased
93
Reduced
79
Closed
52
Calls
$73.6M
Puts
$186K
Net Calls
+$73.4M
Net Calls Change
-$148M

Top Buyers

1
AC
Armistice Capital
New York
+$17M
2
Morgan Stanley
Morgan Stanley
New York
+$15.4M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$14.4M
4
Pacer Advisors
Pacer Advisors
Pennsylvania
+$12M
5
Renaissance Technologies
Renaissance Technologies
New York
+$10.4M

Top Sellers

1
State Street
State Street
Massachusetts
-$33.1M
2
N
Nuveen
North Carolina
-$9.79M
3
BlackRock
BlackRock
New York
-$9.06M
4
UBS Group
UBS Group
Switzerland
-$8.4M
5
SSA
Schonfeld Strategic Advisors
New York
-$6.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
226
Checkpoint Capital
California
– -$5.39M -618,528 Closed
1M
227
13D Management
New York
– -$3.65M -419,284 Closed
EP
228
Edgestream Partners
New Jersey
– -$2.58M -296,287 Closed
QCM
229
QRG Capital Management
Illinois
– -$2.18M -250,227 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
230
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$2.06M -236,000 Closed
DCM
231
Driehaus Capital Management
Illinois
– -$1.83M -210,054 Closed
TCM
232
Tenor Capital Management
New York
– -$1.81M -208,200 Closed
State of New Jersey Common Pension Fund D
233
State of New Jersey Common Pension Fund D
New Jersey
– -$1.62M -185,503 Closed
Arrowstreet Capital
234
Arrowstreet Capital
Massachusetts
– -$1.53M -175,777 Closed
SCM
235
Sio Capital Management
New York
– -$1.3M -149,400 Closed
PFC
236
Phocas Financial Corp
California
– -$1.23K -141,427 Closed
TPSF
237
Texas Permanent School Fund
Texas
– -$1.05M -120,245 Closed
Fisher Asset Management
238
Fisher Asset Management
Washington
– -$914K -104,947 Closed
TC
239
TwinBeech Capital
New York
– -$895K -102,768 Closed
CAM
240
ClariVest Asset Management
California
– -$833K -95,682 Closed
GC
241
GMT Capital
Georgia
– -$730K -83,800 Closed
First Trust Advisors
242
First Trust Advisors
Illinois
– -$713K -81,912 Closed
ACM
243
Aquatic Capital Management
Illinois
– -$686K -78,800 Closed
AIG
244
American International Group
New York
– -$651K -74,691 Closed
Tudor Investment Corp
245
Tudor Investment Corp
Connecticut
– -$560K -64,350 Closed
DA
246
Duality Advisers
Florida
– -$513K -58,915 Closed
Verition Fund Management
247
Verition Fund Management
Connecticut
– -$493K -56,583 Closed
XT
248
XTX Topco
Cayman Islands
– -$485K -55,658 Closed
PD
249
Point72 (DIFC)
United Arab Emirates
– -$365K -41,918 Closed
WAM
250
Wolverine Asset Management
Illinois
– -$356K -40,822 Closed
8 9
10
11 12

IRWD Hedge Fund Activity: Q2 2024 in Review

226 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q2 2024, worth a combined $1.12B — down 26% from $1.5B a quarter earlier.

Sellers outnumbered buyers: 52 funds closed out of IRWD and 21 opened new positions — a net loss of 31 holders — while 79 trimmed existing stakes and 93 added.

The largest buyer was Armistice Capital, adding an estimated $17M. The largest seller was State Street, cutting an estimated $33.1M.

  • 226 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q2 2024, down from 261 in Q1 2024.
  • Funds reported $1.12B of Ironwood Pharmaceuticals stock for Q2 2024, down 26% quarter-over-quarter.
  • 21 funds opened new Ironwood Pharmaceuticals positions in Q2 2024 and 52 closed out, a net change of -31 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q2 2024 was Armistice Capital, an estimated $17M added.
  • The largest Ironwood Pharmaceuticals seller in Q2 2024 was State Street, an estimated $33.1M sold.

Based on aggregated 13F filings for Q2 2024.